[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Valganciclovir API Market, Global Outlook and Forecast 2022-2028

August 2022 | 70 pages | ID: V8C1E72AC1CAEN
Market Monitor Global

US$ 3,250.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Valganciclovir(CAS?175865-60-8) also called Valgancyclovir,is an antiviral medication used to treat cytomegalovirus (CMV) infection in those with HIV/AIDS or following organ transplant.

This report contains market size and forecasts of Valganciclovir API in global, including the following market information:

Global Valganciclovir API Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global Valganciclovir API Market Sales, 2017-2022, 2023-2028, (Kg)

Global top five Valganciclovir API companies in 2021 (%)

The global Valganciclovir API market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Above 98 % Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Valganciclovir API include Biophore India Pharmaceuticals Pvt Ltd, Mylan, Extrovis AG, Aurore Life Sciences, Hetero Drugs, Calyx Chemicals & Pharmaceuticals Limited, DEAFARMA, Aspire Lifesciences Pvt Ltd and Rakshit Drugs, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Valganciclovir API manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Valganciclovir API Market, by Purity, 2017-2022, 2023-2028 ($ Millions) & (Kg)

Global Valganciclovir API Market Segment Percentages, by Purity, 2021 (%)
  • Above 98 %
  • Above 99 %
Global Valganciclovir API Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (Kg)

Global Valganciclovir API Market Segment Percentages, by Application, 2021 (%)
  • Tablets
  • Oral Solution
  • Others
Global Valganciclovir API Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (Kg)

Global Valganciclovir API Market Segment Percentages, By Region and Country, 2021 (%)
  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Russia
    • Nordic Countries
    • Benelux
    • Rest of Europe
  • Asia
    • China
    • Japan
    • South Korea
    • Southeast Asia
    • India
    • Rest of Asia
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Middle East & Africa
    • Turkey
    • Israel
    • Saudi Arabia
    • UAE
    • Rest of Middle East & Africa
Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Valganciclovir API revenues in global market, 2017-2022 (Estimated), ($ millions)

Key companies Valganciclovir API revenues share in global market, 2021 (%)

Key companies Valganciclovir API sales in global market, 2017-2022 (Estimated), (Kg)

Key companies Valganciclovir API sales share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:
  • Biophore India Pharmaceuticals Pvt Ltd
  • Mylan
  • Extrovis AG
  • Aurore Life Sciences
  • Hetero Drugs
  • Calyx Chemicals & Pharmaceuticals Limited
  • DEAFARMA
  • Aspire Lifesciences Pvt Ltd
  • Rakshit Drugs
  • Anthem Biosciences
  • Hanways Chempharm Co., Limited
1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Valganciclovir API Market Definition
1.2 Market Segments
  1.2.1 Market by Purity
  1.2.2 Market by Application
1.3 Global Valganciclovir API Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL VALGANCICLOVIR API OVERALL MARKET SIZE

2.1 Global Valganciclovir API Market Size: 2021 VS 2028
2.2 Global Valganciclovir API Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Valganciclovir API Sales: 2017-2028

3 COMPANY LANDSCAPE

3.1 Top Valganciclovir API Players in Global Market
3.2 Top Global Valganciclovir API Companies Ranked by Revenue
3.3 Global Valganciclovir API Revenue by Companies
3.4 Global Valganciclovir API Sales by Companies
3.5 Global Valganciclovir API Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Valganciclovir API Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Valganciclovir API Product Type
3.8 Tier 1, Tier 2 and Tier 3 Valganciclovir API Players in Global Market
  3.8.1 List of Global Tier 1 Valganciclovir API Companies
  3.8.2 List of Global Tier 2 and Tier 3 Valganciclovir API Companies

4 SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 By Purity - Global Valganciclovir API Market Size Markets, 2021 & 2028
  4.1.2 Above 98 %
  4.1.3 Above 99 %
4.2 By Purity - Global Valganciclovir API Revenue & Forecasts
  4.2.1 By Purity - Global Valganciclovir API Revenue, 2017-2022
  4.2.2 By Purity - Global Valganciclovir API Revenue, 2023-2028
  4.2.3 By Purity - Global Valganciclovir API Revenue Market Share, 2017-2028
4.3 By Purity - Global Valganciclovir API Sales & Forecasts
  4.3.1 By Purity - Global Valganciclovir API Sales, 2017-2022
  4.3.2 By Purity - Global Valganciclovir API Sales, 2023-2028
  4.3.3 By Purity - Global Valganciclovir API Sales Market Share, 2017-2028
4.4 By Purity - Global Valganciclovir API Price (Manufacturers Selling Prices), 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Valganciclovir API Market Size, 2021 & 2028
  5.1.2 Tablets
  5.1.3 Oral Solution
  5.1.4 Others
5.2 By Application - Global Valganciclovir API Revenue & Forecasts
  5.2.1 By Application - Global Valganciclovir API Revenue, 2017-2022
  5.2.2 By Application - Global Valganciclovir API Revenue, 2023-2028
  5.2.3 By Application - Global Valganciclovir API Revenue Market Share, 2017-2028
5.3 By Application - Global Valganciclovir API Sales & Forecasts
  5.3.1 By Application - Global Valganciclovir API Sales, 2017-2022
  5.3.2 By Application - Global Valganciclovir API Sales, 2023-2028
  5.3.3 By Application - Global Valganciclovir API Sales Market Share, 2017-2028
5.4 By Application - Global Valganciclovir API Price (Manufacturers Selling Prices), 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Valganciclovir API Market Size, 2021 & 2028
6.2 By Region - Global Valganciclovir API Revenue & Forecasts
  6.2.1 By Region - Global Valganciclovir API Revenue, 2017-2022
  6.2.2 By Region - Global Valganciclovir API Revenue, 2023-2028
  6.2.3 By Region - Global Valganciclovir API Revenue Market Share, 2017-2028
6.3 By Region - Global Valganciclovir API Sales & Forecasts
  6.3.1 By Region - Global Valganciclovir API Sales, 2017-2022
  6.3.2 By Region - Global Valganciclovir API Sales, 2023-2028
  6.3.3 By Region - Global Valganciclovir API Sales Market Share, 2017-2028
6.4 North America
  6.4.1 By Country - North America Valganciclovir API Revenue, 2017-2028
  6.4.2 By Country - North America Valganciclovir API Sales, 2017-2028
  6.4.3 US Valganciclovir API Market Size, 2017-2028
  6.4.4 Canada Valganciclovir API Market Size, 2017-2028
  6.4.5 Mexico Valganciclovir API Market Size, 2017-2028
6.5 Europe
  6.5.1 By Country - Europe Valganciclovir API Revenue, 2017-2028
  6.5.2 By Country - Europe Valganciclovir API Sales, 2017-2028
  6.5.3 Germany Valganciclovir API Market Size, 2017-2028
  6.5.4 France Valganciclovir API Market Size, 2017-2028
  6.5.5 U.K. Valganciclovir API Market Size, 2017-2028
  6.5.6 Italy Valganciclovir API Market Size, 2017-2028
  6.5.7 Russia Valganciclovir API Market Size, 2017-2028
  6.5.8 Nordic Countries Valganciclovir API Market Size, 2017-2028
  6.5.9 Benelux Valganciclovir API Market Size, 2017-2028
6.6 Asia
  6.6.1 By Region - Asia Valganciclovir API Revenue, 2017-2028
  6.6.2 By Region - Asia Valganciclovir API Sales, 2017-2028
  6.6.3 China Valganciclovir API Market Size, 2017-2028
  6.6.4 Japan Valganciclovir API Market Size, 2017-2028
  6.6.5 South Korea Valganciclovir API Market Size, 2017-2028
  6.6.6 Southeast Asia Valganciclovir API Market Size, 2017-2028
  6.6.7 India Valganciclovir API Market Size, 2017-2028
6.7 South America
  6.7.1 By Country - South America Valganciclovir API Revenue, 2017-2028
  6.7.2 By Country - South America Valganciclovir API Sales, 2017-2028
  6.7.3 Brazil Valganciclovir API Market Size, 2017-2028
  6.7.4 Argentina Valganciclovir API Market Size, 2017-2028
6.8 Middle East & Africa
  6.8.1 By Country - Middle East & Africa Valganciclovir API Revenue, 2017-2028
  6.8.2 By Country - Middle East & Africa Valganciclovir API Sales, 2017-2028
  6.8.3 Turkey Valganciclovir API Market Size, 2017-2028
  6.8.4 Israel Valganciclovir API Market Size, 2017-2028
  6.8.5 Saudi Arabia Valganciclovir API Market Size, 2017-2028
  6.8.6 UAE Valganciclovir API Market Size, 2017-2028

7 MANUFACTURERS & BRANDS PROFILES

7.1 Biophore India Pharmaceuticals Pvt Ltd
  7.1.1 Biophore India Pharmaceuticals Pvt Ltd Corporate Summary
  7.1.2 Biophore India Pharmaceuticals Pvt Ltd Business Overview
  7.1.3 Biophore India Pharmaceuticals Pvt Ltd Valganciclovir API Major Product Offerings
  7.1.4 Biophore India Pharmaceuticals Pvt Ltd Valganciclovir API Sales and Revenue in Global (2017-2022)
  7.1.5 Biophore India Pharmaceuticals Pvt Ltd Key News
7.2 Mylan
  7.2.1 Mylan Corporate Summary
  7.2.2 Mylan Business Overview
  7.2.3 Mylan Valganciclovir API Major Product Offerings
  7.2.4 Mylan Valganciclovir API Sales and Revenue in Global (2017-2022)
  7.2.5 Mylan Key News
7.3 Extrovis AG
  7.3.1 Extrovis AG Corporate Summary
  7.3.2 Extrovis AG Business Overview
  7.3.3 Extrovis AG Valganciclovir API Major Product Offerings
  7.3.4 Extrovis AG Valganciclovir API Sales and Revenue in Global (2017-2022)
  7.3.5 Extrovis AG Key News
7.4 Aurore Life Sciences
  7.4.1 Aurore Life Sciences Corporate Summary
  7.4.2 Aurore Life Sciences Business Overview
  7.4.3 Aurore Life Sciences Valganciclovir API Major Product Offerings
  7.4.4 Aurore Life Sciences Valganciclovir API Sales and Revenue in Global (2017-2022)
  7.4.5 Aurore Life Sciences Key News
7.5 Hetero Drugs
  7.5.1 Hetero Drugs Corporate Summary
  7.5.2 Hetero Drugs Business Overview
  7.5.3 Hetero Drugs Valganciclovir API Major Product Offerings
  7.5.4 Hetero Drugs Valganciclovir API Sales and Revenue in Global (2017-2022)
  7.5.5 Hetero Drugs Key News
7.6 Calyx Chemicals & Pharmaceuticals Limited
  7.6.1 Calyx Chemicals & Pharmaceuticals Limited Corporate Summary
  7.6.2 Calyx Chemicals & Pharmaceuticals Limited Business Overview
  7.6.3 Calyx Chemicals & Pharmaceuticals Limited Valganciclovir API Major Product Offerings
  7.6.4 Calyx Chemicals & Pharmaceuticals Limited Valganciclovir API Sales and Revenue in Global (2017-2022)
  7.6.5 Calyx Chemicals & Pharmaceuticals Limited Key News
7.7 DEAFARMA
  7.7.1 DEAFARMA Corporate Summary
  7.7.2 DEAFARMA Business Overview
  7.7.3 DEAFARMA Valganciclovir API Major Product Offerings
  7.7.4 DEAFARMA Valganciclovir API Sales and Revenue in Global (2017-2022)
  7.7.5 DEAFARMA Key News
7.8 Aspire Lifesciences Pvt Ltd
  7.8.1 Aspire Lifesciences Pvt Ltd Corporate Summary
  7.8.2 Aspire Lifesciences Pvt Ltd Business Overview
  7.8.3 Aspire Lifesciences Pvt Ltd Valganciclovir API Major Product Offerings
  7.8.4 Aspire Lifesciences Pvt Ltd Valganciclovir API Sales and Revenue in Global (2017-2022)
  7.8.5 Aspire Lifesciences Pvt Ltd Key News
7.9 Rakshit Drugs
  7.9.1 Rakshit Drugs Corporate Summary
  7.9.2 Rakshit Drugs Business Overview
  7.9.3 Rakshit Drugs Valganciclovir API Major Product Offerings
  7.9.4 Rakshit Drugs Valganciclovir API Sales and Revenue in Global (2017-2022)
  7.9.5 Rakshit Drugs Key News
7.10 Anthem Biosciences
  7.10.1 Anthem Biosciences Corporate Summary
  7.10.2 Anthem Biosciences Business Overview
  7.10.3 Anthem Biosciences Valganciclovir API Major Product Offerings
  7.10.4 Anthem Biosciences Valganciclovir API Sales and Revenue in Global (2017-2022)
  7.10.5 Anthem Biosciences Key News
7.11 Hanways Chempharm Co., Limited
  7.11.1 Hanways Chempharm Co., Limited Corporate Summary
  7.11.2 Hanways Chempharm Co., Limited Valganciclovir API Business Overview
  7.11.3 Hanways Chempharm Co., Limited Valganciclovir API Major Product Offerings
  7.11.4 Hanways Chempharm Co., Limited Valganciclovir API Sales and Revenue in Global (2017-2022)
  7.11.5 Hanways Chempharm Co., Limited Key News

8 GLOBAL VALGANCICLOVIR API PRODUCTION CAPACITY, ANALYSIS

8.1 Global Valganciclovir API Production Capacity, 2017-2028
8.2 Valganciclovir API Production Capacity of Key Manufacturers in Global Market
8.3 Global Valganciclovir API Production by Region

9 KEY MARKET TRENDS, OPPORTUNITY, DRIVERS AND RESTRAINTS

9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints

10 VALGANCICLOVIR API SUPPLY CHAIN ANALYSIS

10.1 Valganciclovir API Industry Value Chain
10.2 Valganciclovir API Upstream Market
10.3 Valganciclovir API Downstream and Clients
10.4 Marketing Channels Analysis
  10.4.1 Marketing Channels
  10.4.2 Valganciclovir API Distributors and Sales Agents in Global

11 CONCLUSION

12 APPENDIX

12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

LIST OF TABLES

Table 1. Key Players of Valganciclovir API in Global Market
Table 2. Top Valganciclovir API Players in Global Market, Ranking by Revenue (2021)
Table 3. Global Valganciclovir API Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global Valganciclovir API Revenue Share by Companies, 2017-2022
Table 5. Global Valganciclovir API Sales by Companies, (Kg), 2017-2022
Table 6. Global Valganciclovir API Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers Valganciclovir API Price (2017-2022) & (US$/Kg)
Table 8. Global Manufacturers Valganciclovir API Product Type
Table 9. List of Global Tier 1 Valganciclovir API Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Valganciclovir API Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Purity – Global Valganciclovir API Revenue, (US$, Mn), 2021 & 2028
Table 12. By Purity - Global Valganciclovir API Revenue (US$, Mn), 2017-2022
Table 13. By Purity - Global Valganciclovir API Revenue (US$, Mn), 2023-2028
Table 14. By Purity - Global Valganciclovir API Sales (Kg), 2017-2022
Table 15. By Purity - Global Valganciclovir API Sales (Kg), 2023-2028
Table 16. By Application – Global Valganciclovir API Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global Valganciclovir API Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global Valganciclovir API Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global Valganciclovir API Sales (Kg), 2017-2022
Table 20. By Application - Global Valganciclovir API Sales (Kg), 2023-2028
Table 21. By Region – Global Valganciclovir API Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global Valganciclovir API Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global Valganciclovir API Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global Valganciclovir API Sales (Kg), 2017-2022
Table 25. By Region - Global Valganciclovir API Sales (Kg), 2023-2028
Table 26. By Country - North America Valganciclovir API Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America Valganciclovir API Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America Valganciclovir API Sales, (Kg), 2017-2022
Table 29. By Country - North America Valganciclovir API Sales, (Kg), 2023-2028
Table 30. By Country - Europe Valganciclovir API Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe Valganciclovir API Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe Valganciclovir API Sales, (Kg), 2017-2022
Table 33. By Country - Europe Valganciclovir API Sales, (Kg), 2023-2028
Table 34. By Region - Asia Valganciclovir API Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia Valganciclovir API Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia Valganciclovir API Sales, (Kg), 2017-2022
Table 37. By Region - Asia Valganciclovir API Sales, (Kg), 2023-2028
Table 38. By Country - South America Valganciclovir API Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America Valganciclovir API Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America Valganciclovir API Sales, (Kg), 2017-2022
Table 41. By Country - South America Valganciclovir API Sales, (Kg), 2023-2028
Table 42. By Country - Middle East & Africa Valganciclovir API Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa Valganciclovir API Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa Valganciclovir API Sales, (Kg), 2017-2022
Table 45. By Country - Middle East & Africa Valganciclovir API Sales, (Kg), 2023-2028
Table 46. Biophore India Pharmaceuticals Pvt Ltd Corporate Summary
Table 47. Biophore India Pharmaceuticals Pvt Ltd Valganciclovir API Product Offerings
Table 48. Biophore India Pharmaceuticals Pvt Ltd Valganciclovir API Sales (Kg), Revenue (US$, Mn) and Average Price (US$/Kg) (2017-2022)
Table 49. Mylan Corporate Summary
Table 50. Mylan Valganciclovir API Product Offerings
Table 51. Mylan Valganciclovir API Sales (Kg), Revenue (US$, Mn) and Average Price (US$/Kg) (2017-2022)
Table 52. Extrovis AG Corporate Summary
Table 53. Extrovis AG Valganciclovir API Product Offerings
Table 54. Extrovis AG Valganciclovir API Sales (Kg), Revenue (US$, Mn) and Average Price (US$/Kg) (2017-2022)
Table 55. Aurore Life Sciences Corporate Summary
Table 56. Aurore Life Sciences Valganciclovir API Product Offerings
Table 57. Aurore Life Sciences Valganciclovir API Sales (Kg), Revenue (US$, Mn) and Average Price (US$/Kg) (2017-2022)
Table 58. Hetero Drugs Corporate Summary
Table 59. Hetero Drugs Valganciclovir API Product Offerings
Table 60. Hetero Drugs Valganciclovir API Sales (Kg), Revenue (US$, Mn) and Average Price (US$/Kg) (2017-2022)
Table 61. Calyx Chemicals & Pharmaceuticals Limited Corporate Summary
Table 62. Calyx Chemicals & Pharmaceuticals Limited Valganciclovir API Product Offerings
Table 63. Calyx Chemicals & Pharmaceuticals Limited Valganciclovir API Sales (Kg), Revenue (US$, Mn) and Average Price (US$/Kg) (2017-2022)
Table 64. DEAFARMA Corporate Summary
Table 65. DEAFARMA Valganciclovir API Product Offerings
Table 66. DEAFARMA Valganciclovir API Sales (Kg), Revenue (US$, Mn) and Average Price (US$/Kg) (2017-2022)
Table 67. Aspire Lifesciences Pvt Ltd Corporate Summary
Table 68. Aspire Lifesciences Pvt Ltd Valganciclovir API Product Offerings
Table 69. Aspire Lifesciences Pvt Ltd Valganciclovir API Sales (Kg), Revenue (US$, Mn) and Average Price (US$/Kg) (2017-2022)
Table 70. Rakshit Drugs Corporate Summary
Table 71. Rakshit Drugs Valganciclovir API Product Offerings
Table 72. Rakshit Drugs Valganciclovir API Sales (Kg), Revenue (US$, Mn) and Average Price (US$/Kg) (2017-2022)
Table 73. Anthem Biosciences Corporate Summary
Table 74. Anthem Biosciences Valganciclovir API Product Offerings
Table 75. Anthem Biosciences Valganciclovir API Sales (Kg), Revenue (US$, Mn) and Average Price (US$/Kg) (2017-2022)
Table 76. Hanways Chempharm Co., Limited Corporate Summary
Table 77. Hanways Chempharm Co., Limited Valganciclovir API Product Offerings
Table 78. Hanways Chempharm Co., Limited Valganciclovir API Sales (Kg), Revenue (US$, Mn) and Average Price (US$/Kg) (2017-2022)
Table 79. Valganciclovir API Production Capacity (Kg) of Key Manufacturers in Global Market, 2020-2022 (Kg)
Table 80. Global Valganciclovir API Capacity Market Share of Key Manufacturers, 2020-2022
Table 81. Global Valganciclovir API Production by Region, 2017-2022 (Kg)
Table 82. Global Valganciclovir API Production by Region, 2023-2028 (Kg)
Table 83. Valganciclovir API Market Opportunities & Trends in Global Market
Table 84. Valganciclovir API Market Drivers in Global Market
Table 85. Valganciclovir API Market Restraints in Global Market
Table 86. Valganciclovir API Raw Materials
Table 87. Valganciclovir API Raw Materials Suppliers in Global Market
Table 88. Typical Valganciclovir API Downstream
Table 89. Valganciclovir API Downstream Clients in Global Market
Table 90. Valganciclovir API Distributors and Sales Agents in Global Market

LIST OF FIGURES

Figure 1. Valganciclovir API Segment by Purity
Figure 2. Valganciclovir API Segment by Application
Figure 3. Global Valganciclovir API Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Valganciclovir API Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Valganciclovir API Revenue, 2017-2028 (US$, Mn)
Figure 7. Valganciclovir API Sales in Global Market: 2017-2028 (Kg)
Figure 8. The Top 3 and 5 Players Market Share by Valganciclovir API Revenue in 2021
Figure 9. By Purity - Global Valganciclovir API Sales Market Share, 2017-2028
Figure 10. By Purity - Global Valganciclovir API Revenue Market Share, 2017-2028
Figure 11. By Purity - Global Valganciclovir API Price (US$/Kg), 2017-2028
Figure 12. By Application - Global Valganciclovir API Sales Market Share, 2017-2028
Figure 13. By Application - Global Valganciclovir API Revenue Market Share, 2017-2028
Figure 14. By Application - Global Valganciclovir API Price (US$/Kg), 2017-2028
Figure 15. By Region - Global Valganciclovir API Sales Market Share, 2017-2028
Figure 16. By Region - Global Valganciclovir API Revenue Market Share, 2017-2028
Figure 17. By Country - North America Valganciclovir API Revenue Market Share, 2017-2028
Figure 18. By Country - North America Valganciclovir API Sales Market Share, 2017-2028
Figure 19. US Valganciclovir API Revenue, (US$, Mn), 2017-2028
Figure 20. Canada Valganciclovir API Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico Valganciclovir API Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe Valganciclovir API Revenue Market Share, 2017-2028
Figure 23. By Country - Europe Valganciclovir API Sales Market Share, 2017-2028
Figure 24. Germany Valganciclovir API Revenue, (US$, Mn), 2017-2028
Figure 25. France Valganciclovir API Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. Valganciclovir API Revenue, (US$, Mn), 2017-2028
Figure 27. Italy Valganciclovir API Revenue, (US$, Mn), 2017-2028
Figure 28. Russia Valganciclovir API Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries Valganciclovir API Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux Valganciclovir API Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia Valganciclovir API Revenue Market Share, 2017-2028
Figure 32. By Region - Asia Valganciclovir API Sales Market Share, 2017-2028
Figure 33. China Valganciclovir API Revenue, (US$, Mn), 2017-2028
Figure 34. Japan Valganciclovir API Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea Valganciclovir API Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia Valganciclovir API Revenue, (US$, Mn), 2017-2028
Figure 37. India Valganciclovir API Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America Valganciclovir API Revenue Market Share, 2017-2028
Figure 39. By Country - South America Valganciclovir API Sales Market Share, 2017-2028
Figure 40. Brazil Valganciclovir API Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina Valganciclovir API Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa Valganciclovir API Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa Valganciclovir API Sales Market Share, 2017-2028
Figure 44. Turkey Valganciclovir API Revenue, (US$, Mn), 2017-2028
Figure 45. Israel Valganciclovir API Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia Valganciclovir API Revenue, (US$, Mn), 2017-2028
Figure 47. UAE Valganciclovir API Revenue, (US$, Mn), 2017-2028
Figure 48. Global Valganciclovir API Production Capacity (Kg), 2017-2028
Figure 49. The Percentage of Production Valganciclovir API by Region, 2021 VS 2028
Figure 50. Valganciclovir API Industry Value Chain
Figure 51. Marketing Channels


More Publications